Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (665)	6/27/2001 7:40:03 PM
From: Crossy	Read Replies (1) \| Respond to of 1784

Nigel, wanted to get back to OXIG.L (Oxford Instruments) They make magnets, LTS-MRI superconductor magnets, scientific instruments and compound semiconductor equipment (sputtering systems, competitor of VECO and MKSI) OXIG is trading at 210p now after they announced their restructuring and return back to profitability. The stock shot up from 150 to 210p but I believe there is room for much more. Today OXIG had again very high volume in London, around 500.000 shares being traded. Now the valuations for such a high-tech gem like OXIG are truly compelling: biz.yahoo.com Company is free of LT debt, net cash positive (over st debt), it pays a DIVIDEND (8p for 2000) and it's trading around book value now. Price/Sales is 0.60 but that excludes all the revenues from their cash-cow division that produces LTS MRI magnets (JV with Siemens) Now the real competitor in this market is IMG (Amex). Look at their ratios. PSR of 3.50. OXIG just commends a PSR of 0.60. Very cheap. Plus they are one of the few companies with SUPERCONDUCTOR EXPERTISE and a hand onto Europe's research programs. IMHO longterm I do see a convergence in valuations of OXIG towards the ratios that IMG currently displays, provided that OXIG can sustain its pace to improved profitability and high-tech expertise. From the stats alone I feel that a 5-bagger couldn't be ruled out longterm with OXIG. When you opened the "research" link above you will find that NO BROKER is currently out with a "BUY" rating on OXIG but buying interest was sky-high since April. Next level of resistance is 250p. If we clear that then OXIG might be ready to fly. A single upgrade would do and currently 4 brokers are covering it.. best wishes CROSSY BTW: I hope mentioning OXIG won't violate your thread's culture. OXIG is biotech related to some extent but I would call it more a scientific-instrumentation company..